multiple myeloma...with multiple myeloma and a high tumor burden should be considered at greater...
Post on 28-Sep-2020
2 Views
Preview:
TRANSCRIPT
• Review efficacy and safety data supporting the combination indications • Communicate important safety information for KYPROLIS® • Discuss the dosing and administration of KYPROLIS® combinations
Jennifer Knoche, RN, BSN, OCN, BMTCN Lead Practice Nurse UCSF Hematology/BMT Ambulatory Care Center
KYPROLIS® (carfilzomib) Regimens for the Treatment of Patients with Relapsed/Refractory
Multiple Myeloma
Forbes Mill Steakhouse 200 Sycamore Valley Road West Danville, CA 94526 (925) 552-0505
Carlo Gabaldon at (925) 330-9318 and/or gabaldon@amgen.com
Tuesday February 19, 2019 6:30 PM Pacific
AHM 866-700-9291
KYPROLIS® (carfilzomib) Regimens for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma
KYPROLIS® (carfilzomib) Regimens for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma
AHM 866-700-9291
KYPROLIS® (carfilzomib) Regimens for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma
top related